Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Abdalla S, Lother H, El Missiry A, Langer A, Sergeev P, El Faramawy Y, Quitterer U. Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease. J Biol Chem. 2009 Mar 6;284(10):6554-65. PubMed Abstract

  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 

REAGENTS/MATERIAL:
Immunoblotting and immunohistochemistry: The following antibodies were used for immunoblotting, affinity purification and immunohistochemistry: affinity-purified rabbit/rat polyclonal anti-AT2 antibodies (raised against an antigen encompassing amino acids 320-349 of the human AT2 receptor); affinity-purified rabbit polyclonal anti-AT2 antibodies (raised against an antigen encompassing amino acids 16-35 of the human or mouse AT2 receptor); affinity-purified rabbit/rat polyclonal anti-M1 antibodies (raised against an antigen encompassing amino acids 231-350 of the human M2 receptor); affinity-purified rabbit polyclonal anti-transglutaminase antibodies (raised against an antigen encompassing amino acids 1-20 of mouse transglutaminase-2); affinity-purified rabbit polyclonal anti-Gαq/11 antibodies (raised against the C-terminus of Gαq/11).
Protein detection in immunoblot: Aβ in the prefrontal cortex specimens indicative of Aβ plaque load was assessed by immunoblot with Aβ-specific rat polyclonal antibodies. Affinity-purified antibodies or F(ab)2 fragments of the respective antibodies pre-absorbed to human and mouse proteins, respectively, were used for detection of AT2, AT1 receptors, and Gαq/11.
Immunohistochemistry, radio-immunohistochemistry and immunofluorescence: Immunohistochemical staining of transglutaminase-2, AT2 receptor, and M1 receptor were performed with F(ab)2 fragments of pre-absorbed affinity-purified polyclonal antibodies. Sections were stained for Aβ plaques with monoclonal antibodies crossreacting with residues 1-12 of Aβ (BAM-10) (Sigma Aldrich). Phosphorylated tau was visualized with AT8 antibodies (Pierce). Immunohistochemistry with antibodies to MAP2 (Sigma Aldrich) was used as a marker of neuronal cell bodies and dendrites. Lentivirus-driven expression of HA transglutaminase-2 was visualized by radio-immunohistochemistry applying anti-HA antibodies (Santa Cruz). Neuronal cell bodies of CA1 were quantified by [125I]-labeled NeuN antibodies.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad